Efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes
about
The Glucose-lowering Efficacy of Sitagliptin in Obese Japanese Patients with Type 2 Diabetes.Prediction of the effect on antihyperglycaemic action of sitagliptin by plasma active form glucagon-like peptide-1.Sitagliptin: A Review in Type 2 Diabetes.Study Protocol for the Initial Choice of DPP-4 Inhibitor in Japanese Patients with Type 2 diabetes Mellitus: Effect of Linagliptin on QOL (INTEL-QOL) Trial.
P2860
Efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes
@ast
Efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes
@en
type
label
Efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes
@ast
Efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes
@en
prefLabel
Efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes
@ast
Efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes
@en
P2093
P2860
P356
P1476
Efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes
@en
P2093
Hideaki Funayama
Hirotoshi Ohmura
Hiroyuki Daida
Joe Matsuoka
Masahiro Sugawara
SPIRITS-J Study Investigators
Tomoya Mita
Yoshinobu Taneda
P2860
P304
P356
10.14740/JOCMR1983W
P577
2015-02-09T00:00:00Z